Chris Cargill

“And just a quick disclaimer, please note that today's presentation does contain forward-looking statements, and the actual results may differ from them. The details are here on slide number two.”

“Maybe actually I'll start by sort of describing who we are. You know, we are a Japanese biotechnology company, one of the very few Japanese biotechnology companies.”

“And I have a lot to share with you today. Now, I want to begin by addressing our share price. Your frustration is legitimate, and it is shared by every member of our leadership team, including me, personally.”

“Now, let me start by saying FY 2025's financial results, particularly the operating profit level, were unacceptable.”